The Genome 10K’s Vertebrate Genomes Project (VGP) and the Earth BioGenome Project (EBP) are moving ahead in their quests to sequence the genomes of all living vertebrate species and all eukaryotic species, respectively.
Two ongoing efforts to produce new human genome assemblies are combining ultra-long nanopore reads with other types of sequencing and mapping data to generate gapless or near-gapless assemblies that can serve as reference genomes for future studies.
Gene regulation is offering a new class of targets that operate on a higher level than DNA sequences and epigenetic markers: 3-D genomic structures. While strategies to drug the 3-D genome are still in their infancy, the growing accessibility of mapping technologies is paving the way for translation in cancer and developmental disorders.
The Genome 10K consortium (G10K) announces the official launch of the Vertebrate Genome Project (VGP) and its first release of 15 new, high-quality reference genomes for 14 species representing all five vertebrate classes – mammals, birds, reptiles, amphibians, and fishes. As a selected partner for the current Phase 1 of VGP, Arima Genomics delivered high quality Hi-C proximity-ligation (referred to as Arima-HiC) data necessary to achieve whole chromosome-spanning assemblies.
Arima-HiC services is selected by the prestigious G10K consortium to generate ‘near-gapless’ reference genome assemblies for all vertebrate order species (phase 1). In a second related story, Arima Genomics today launches an early access program for its rapid, robust, and easy-to-use Arima-HiC kits to satisfy the high demand for HiC technology.
SAN DIEGO--(BUSINESS WIRE)--Arima Genomics, Inc., a company focused on research tools to accelerate the understanding of genome sequence and structure toward their role in human health and disease, announces that it has completed its Series A round of financing. Agilent Technologies, Inc. (NYSE: A) and Cowin Venture led this round, joined by Vectr Ventures and Berkeley Catalyst Fund.
SAN DIEGO--(BUSINESS WIRE)--Arima Genomics, Inc., a biotechnology company focused on accelerating the adoption of genome structure information toward medical research, diagnosis and therapy, announced today the full commercial launch of the HiChIP application built on its existing Arima-HiC platform. With this launch, researchers can now obtain long-range chromatin interactions specifically enriched at genomic locations occupied by proteins of interest from a single experiment, enabling speed to discovery and publication with reduced costs.